Showing results (641-650 of 689) with videos related to

Sort By:
Pageof 69
Modern Rheumatology|December 15, 2021
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1)Yoshiya Tanaka, Tsukasa Matsubara, Tatsuya Atsumi, et al.
Arthritis and Rheumatism|January 26, 2013
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic studyDésirée van der Heijde, Yoshiya Tanaka, Roy Fleischmann, et al.
Modern Rheumatology|August 3, 2022
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week resultsYoshiya Tanaka, Tsukasa Matsubara, Tatsuya Atsumi, et al.
Metabolites|April 21, 2022
Restricting Branched-Chain Amino Acids within a High-Fat Diet Prevents ObesityMing Liu, Yiheng Huang, Hongwei Zhang, et al.
Clinical Pharmacology and Therapeutics|December 3, 2020
Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry PerspectiveTycho Heimbach, Yuan Chen, Jun Chen, et al.
Annals of the Rheumatic Diseases|May 21, 2015
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search updateMichaela A Stoffer, Monika M Schoels, Josef S Smolen, et al.
International Journal of Rheumatic Diseases|February 28, 2019
2018 update of the APLAR recommendations for treatment of rheumatoid arthritisChak Sing Lau, Faith Chia, Leonila Dans, et al.
Annals of the Rheumatic Diseases|May 28, 2011
The Ile585Val TRPV1 variant is involved in risk of painful knee osteoarthritisAna M Valdes, Gert De Wilde, Sally A Doherty, et al.
Annals of the Rheumatic Diseases|January 28, 2021
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trialBernard Combe, Alan Kivitz, Yoshiya Tanaka, et al.
Lancet (London, England)|February 8, 2011
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trialSandra V Navarra, Renato M Guzmán, Alberto E Gallacher, et al.
Pageof 69